Navigation Links
Former Stryker CEO Takes Reins at sBioMed

OREM, Utah, Nov. 1, 2012 /PRNewswire/ -- sBioMed, an emerging leader in infection control, announced today that Stephen P. MacMillan, former Chairman and CEO of Stryker, has joined the company as Chief Executive Officer and become an owner of the company.

sBioMed has developed breakthrough patented antimicrobial technologies, offering an unprecedented level of efficacy and safety. The company's flagship product STERIPLEX SD is the first and only Clostridium difficile sporicide and broad-spectrum, one-step disinfectant, which is also remarkably safe, completely non-fuming, non-corrosive, and contains no bleach.

The technology is similar to the company's anthrax remediation product, STERIPLEX Ultra, the only EPA-registered product available that kills anthrax spores.

Brian Larson, sBioMed's cofounder and chairman, said, "After a decade of research, over 500 studies and EPA-registration, we are excited to enter the full-scale commercialization process.  With Steve's leadership, we can help eliminate Healthcare-Associated Infections (HAIs) globally."

"It's rare to find a product with such revolutionary potential," MacMillan said. "STERIPLEX SD will save lives, improve healthcare delivery and protect caregivers, while reducing healthcare costs and preserving the environment.  I'm also excited about the chance to work with the sBioMed team to build a very special global company based in Utah."

With the growing incidence of C. diff and other superbugs, infections are now the fourth leading killer in the U.S., at a cost to the U.S. healthcare system of tens of billions of dollars annually.  Effective January 1, 2013, costs associated with HAIs will no longer be reimbursed, giving hospitals a strong incentive to eliminate HAIs. Hospitals currently employing STERIPLEX SD have charted a significant drop in HAIs.

STERIPLEX SD is EPA-registered for use on food contact surfaces (NSF D2) and can even be used on children's toys.  With the best MSDS health rating of "0," STERIPLEX SD provides broad-spectrum sporicidal disinfection for institutions that want to reduce HAIs, increase workplace safety, and eliminate their use of volatile organic compounds (VOCs).

Learn more about STERIPLEX on the company's website,

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
2. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
3. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
4. PharmaVentures Helps Secure Investor for Former MSD Research Site
5. Dr. Michael Yaremchuk, Leading Performer of Custom-Designed Facial Implants, Pioneers Bespoke Plastic Surgery
6. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
7. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
8. New Kit Takes the Uncertainty Out of Lymphoma Diagnosis
9. Terminator-style info-vision takes step towards reality
10. Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields
11. Quammen Health Care Consultants Takes Over Information Technology Reins at Faith Regional Health Services
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... of the year and one of the premier annual events for pharmaceutical manufacturing: ... from 8–11 November 2015, where ISPE hosted the largest number of attendees in ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
Breaking Biology Technology:
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/29/2015)... YORK , Oct. 29, 2015 ... technology, announced a partnership with 2XU, a global ... to deliver a smart hat with advanced bio-sensing ... and other athletes to monitor key biometrics to ... the strategic partnership, the two companies will bring together ...
(Date:10/27/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leader ... adopted the Synaptics ® ClearPad ® Series ... newest flagship smartphones, the Nexus 5X by LG and ... --> --> Synaptics works closely with ... in the joint development of next generation technologies. Together, ...
Breaking Biology News(10 mins):